# Dexmedetomidine Reduces Atrial Fibrillation in Mechanically Ventilated Patients With COVID-19 Pneumonia

> **NCT05171985** · NA · UNKNOWN · sponsor: **Tanta University** · enrollment: 144 (estimated)

## Conditions studied

- COVID-19 Pneumonia
- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Dexmedetomidine sedation

## Key facts

- **NCT ID:** NCT05171985
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2021-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05171985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05171985, "Dexmedetomidine Reduces Atrial Fibrillation in Mechanically Ventilated Patients With COVID-19 Pneumonia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05171985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*